Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells
暂无分享,去创建一个
Ping Li | S. Fu | Qing Zhang | M. Veldwijk | Zhao-bin Li | Wen-cai Xu
[1] Ping Li,et al. Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells , 2013, BMC Cancer.
[2] R. Stahel,et al. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin , 2012, BMC Cancer.
[3] J. Olson,et al. K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas. , 2012, Cancer letters.
[4] S. Leung,et al. Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes , 2012, Breast Cancer Research and Treatment.
[5] K. Liang,et al. Constitutively active Harvey Ras confers resistance to epidermal growth factor receptor-targeted therapy with cetuximab and gefitinib. , 2011, Cancer letters.
[6] R. Deng,et al. PKB/Akt promotes DSB repair in cancer cells through upregulating Mre11 expression following ionizing radiation , 2011, Oncogene.
[7] Kuo Ann Lee,et al. Hormone receptors and HER-2 status as surrogates for breast cancer molecular subtypes prognosticate for disease control in node negative Asian patients treated with breast conservation therapy. , 2011, Annals of the Academy of Medicine, Singapore.
[8] D. Powe,et al. Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism , 2011, BMC Cancer.
[9] Qifeng Yang,et al. Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] C. Livasy,et al. Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts. , 2010, International journal of radiation oncology, biology, physics.
[11] T. Nielsen,et al. Breast cancer subtypes and the risk of local and regional relapse. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] F. Liu,et al. EGFR inhibitor C225 increases the radiosensitivity of human lung squamous cancer cells , 2010, Cancer Cell International.
[13] J. M. Shields,et al. Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] R C Roovers,et al. Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. , 2009, Current cancer drug targets.
[15] S. Thomson,et al. Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. , 2008, Cancer research.
[16] P. Pandolfi,et al. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. , 2008, The Journal of clinical investigation.
[17] K. W. Kim,et al. Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer , 2006, Molecular Cancer Therapeutics.
[18] C. Perou,et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma , 2006, Modern Pathology.
[19] M. Pollak,et al. Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells , 2005, Breast Cancer Research.
[20] L Cawkwell,et al. Radioresistance in carcinoma of the breast. , 2004, Breast.
[21] C. Shimizu,et al. Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis. , 2004, Human pathology.
[22] R. Nicholson,et al. Nonendocrine Pathways and Endocrine Resistance , 2004, Clinical Cancer Research.
[23] J. Slingerland,et al. Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression , 2003, Cell cycle.
[24] R. Nicholson,et al. Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization , 2003, Breast Cancer Research.
[25] Leila Mohammadi,et al. BMC Cancer , 2001 .
[26] R. Schmidt-Ullrich,et al. Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. , 1999, Molecular biology of the cell.